Emily Day
University of Delaware
H-index: 31
North America-United States
Top articles of Emily Day
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer
ACS omega
2024/3/16
Membrane-Cloaked Nanoparticles for RNA Interference of β-Catenin in Triple-Negative Breast Cancer
ACS Biomaterials Science & Engineering
2024/2/2
Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles
2023/12/31
Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles
Drug Delivery and Translational Research
2023/12
Novel Bone Marrow/HSC-Targeted, Megakaryocyte-Derived Extracellular Vesicle Delivery Modality for In Vivo Gene Therapy
Blood
2023/11/28
Nanotechnologies for the detection and treatment of endometriosis
2023/11/16
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer
Molecular Pharmaceutics
2023/7/17
Megakaryocyte membrane‐wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells
Bioengineering & Translational Medicine
2023/5
E-Selectin Targeted Gold Nanoshells to Inhibit Breast Cancer Cell Binding to Lung Endothelial Cells
ACS applied nano materials
2023/1/9
Isocorrole-Loaded Polymer Nanoparticles for Photothermal Therapy under 980 nm Light Excitation
Acs Omega
2022/10/6
Membrane-wrapped nanoparticles for enhanced chemotherapy of acute myeloid leukemia
ACS biomaterials science & engineering
2022/9/14
Membrane-wrapped nanoparticles for photothermal cancer therapy
2022/8/12
Membrane-wrapped nanoparticles for nucleic acid delivery
2022
Critical evaluation of different lysosomal labeling methods used to analyze RNA nanocarrier trafficking in cells
Bioconjugate chemistry
2021/9/20
Biomembrane-covered nanoparticles (bionps) for delivering active agents to stem cells
2021/9/9
Antibody nanocarriers for cancer management
2021/9/1
Gold nanoparticle biodistribution in pregnant mice following intravenous administration varies with gestational age
Nanomedicine: Nanotechnology, Biology and Medicine
2021/8/1
Introduction to Editorial Board Member: Professor Jennifer L. West
Bioengineering & Translational Medicine
2021/5
Biomimetic nanoparticles for the treatment of hematologic malignancies
2021/4
Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies
2021/3/1
Co-Authors
